PT-141 (Bremelanotide)
PT-141, also known as Bremelanotide, is a synthetic peptide analog derived from the melanocortin peptide family. It is primarily studied in neuroscience and endocrine research due to its interaction with melanocortin receptors, which are involved in complex signaling pathways affecting central nervous system communication and cellular regulation.
In laboratory research, PT-141 is valued for its receptor-targeted activity, particularly its interaction with melanocortin receptor subtypes. These receptors are distributed throughout the central nervous system and peripheral tissues, making PT-141 a relevant tool for exploring peptide-mediated signaling mechanisms.
One of the defining characteristics of PT-141 is its enhanced stability and receptor selectivity compared to endogenous melanocortin peptides. This allows researchers to observe precise signaling effects over controlled experimental periods, supporting reproducible laboratory results.
PT-141 is frequently included in studies examining neuropeptide signaling and central nervous system modulation. Its activity provides insight into how targeted peptide-receptor interactions influence communication between neural circuits in experimental models.
The peptide is also studied for its effects on downstream molecular pathways associated with melanocortin signaling. Researchers investigate how PT-141 impacts gene expression, cellular activation, and receptor-mediated signal transduction under controlled conditions.
PT-141’s compact structure contributes to predictable molecular behavior in laboratory settings, making it suitable for comparative studies and protocol standardization.
Researchers often examine PT-141 alongside other melanocortin analogs to explore differences in receptor affinity, signaling intensity, and activation duration. This comparative approach helps clarify structure–activity relationships in peptide biology.
Unlike broad-acting compounds, PT-141 operates through selective receptor modulation, providing precise research control over the pathways of interest rather than widespread systemic effects.
PT-141 is also used in studies investigating central versus peripheral peptide signaling. Its receptor-targeted design allows differentiation between signaling effects in various tissue types within experimental models.
Because melanocortin signaling intersects multiple biological systems, PT-141 is frequently employed in systems-based research to study integrated cellular responses rather than isolated pathways.
The peptide’s well-characterized profile supports reproducibility and standardization in laboratory research. Its stability, selectivity, and receptor-targeted behavior make it a valuable tool for advanced neuroendocrine and peptide research.
PT-141 continues to attract scientific interest due to its precision, structural refinement, and relevance in understanding complex peptide-mediated signaling networks.
Its targeted design, predictable behavior, and receptor specificity make PT-141 an important research compound for studying central nervous system communication and peptide receptor biology.
New
PT-141 (Bremelanotide) 10mg
$58.00
PT-141, also known as Bremelanotide, is a synthetic peptide analog derived from the melanocortin peptide family. It is primarily studied in neuroscience and endocrine research due to its interaction with melanocortin receptors, which are involved in complex signaling pathways affecting central nervous system communication and cellular regulation.
Description
Shipping & Delivery
Related products
AOD9604 6mg
AOD9604 is a modified version of the hGH fragment 176-191 peptide (contains a di-sulfide bridge) and thus a derivative of human growth hormone (hGH). Originally developed as a lipolytic (fat burning) compound, AOD9604 has shown benefit in studies of heart disease, osteoarthritis/cartilage repair, and metabolic syndrome. AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis in animal studies.
BPC-157 10mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
BPC-157, TB-500 (Blend)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
Dihexa (5mg x 60 Capsules = 300mg)
Dihexa is a small peptide-derived compound designed to support cognitive function and brain regeneration. It acts by activating the HGF/c-Met signaling pathway, which plays a critical role in forming new synaptic connections and enhancing neuroplasticity. Dihexa also mimics the action of brain-derived neurotrophic factor (BDNF), a key molecule involved in learning, memory, and neuronal survival. Preclinical research studies have shown that Dihexa can significantly improve memory consolidation and reverse cognitive deficits in models of Alzheimer’s disease, traumatic brain injury, and stroke. Unlike traditional nootropics or growth factors with poor blood–brain barrier penetration, Dihexa is orally bioavailable and metabolically stable, allowing for targeted CNS effects. Its unique mechanism positions it as a promising research compound for neurodegenerative conditions, offering potential in synaptic repair, inflammation reduction, and long-term cognitive enhancement. 
Melanotan 2 (MT2) (3mg x 10 Vials = 30mg)
Melanotan-2 (MT-2) is a synthetic derivative of human alpha-melanocyte-stimulating hormone (α-MSH), developed at the University of Arizona in the 1980s. The initial purpose was to create a sunless tanning alternative, inspired by α-MSH's ability to induce sexual arousal and skin darkening in rodents. However, as research progressed, MT-2's diverse effects were unveiled. These include enhancing sexual arousal, promoting skin pigmentation, reducing compulsive behavior, managing addiction, suppressing hunger, decreasing glucagon production, and even potentially reversing certain features associated with autism. Melanotan-2 research has shown it to enhance sexual arousal, promote skin pigmentation through melanocyte activation and reduce compulsive/addictive behaviors.
Tesamorelin, Ipamorelin 8mg (Blend)
The scientific community continues to explore new applications for Ipamorelin, particularly in regenerative biology, metabolic optimization, and long-term health research. As understanding of GH and IGF-1 pathways deepens, Ipamorelin remains a cornerstone tool for investigating the body’s natural growth and repair mechanisms.
Reviews
There are no reviews yet.